Literature DB >> 89074

Complete deficiency of constitutive heterochromatin on a human chromosome 9.

C H Buys, J M Ypma, W L Gouw.   

Abstract

In cultured amniotic fluid cells a mediocentric chromosome 9 appeared to be completely deficient in constitutive heterochromatin when stained with distamycin A and DAPI. In addition, this deficient chromosome was found in a blood cell culture from the father. Both the father and the child after birth were phenotypically normal. Evidently, a considerable heterozygotic deficit of chromosome 9 heterochromatin can be tolerated without affecting the phenotype. The heterochromatin defect was also shown by G11-staining. Distamycin A-DAPI staining is highly reproducible and is recommended as a fluorescent alternative to often less successful G11-methods for the detection of heteromorphism of chromosome 9.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 89074     DOI: 10.1007/BF00277634

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  7 in total

1.  Morphologic variability of human chromosomes: polymorphism of constitutive heterochromatin.

Authors:  P K Ghosh; I P Singh
Journal:  Hum Genet       Date:  1976-05-19       Impact factor: 4.132

2.  Frequency of 9qh+ and risk of chromosome aberrations in the progeny of individuals with 9qh+.

Authors:  J Nielsen; U Friedrich; A B Hreidarsson; E Zeuthen
Journal:  Humangenetik       Date:  1974

3.  Specific cytological recognition of the heterochromatic segment of number 9 chromosome in man.

Authors:  R Gagné; C Laberge
Journal:  Exp Cell Res       Date:  1972-07       Impact factor: 3.905

4.  The chromosomal location of human satellite DNA 3.

Authors:  K W Jones; J Prosser; G Corneo; E Ginelli
Journal:  Chromosoma       Date:  1973-07-18       Impact factor: 4.316

5.  Letter: A1 and C9 marker chromosomes in children with combined minor and major malformations.

Authors:  J Kunze; G Mau
Journal:  Lancet       Date:  1975-02-01       Impact factor: 79.321

6.  Chromosomal variants and nondisjunction.

Authors:  J H Ford; P Lester
Journal:  Cytogenet Cell Genet       Date:  1978

7.  Modification of DAPI banding on human chromosomes by prestaining with a DNA-binding oligopeptide antibiotic, distamycin A.

Authors:  D Schweizer; P Ambros; M Andrle
Journal:  Exp Cell Res       Date:  1978-02       Impact factor: 3.905

  7 in total
  6 in total

1.  A comparison of constitutive heterochromatin staining methods in two cases of familial heterochromatin deficiencies.

Authors:  C H Buys; G J Anders; W L Gouw; J M Borkent-Ypma; J A Blenkers-Platter
Journal:  Hum Genet       Date:  1979-11-01       Impact factor: 4.132

2.  Absence of constitutive heterochromatin in a partially identified supernumerary marker chromosome.

Authors:  G S Pai; G H Thomas; P J Benke
Journal:  J Med Genet       Date:  1981-10       Impact factor: 6.318

3.  Structural organization of the heterochromatic region of human chromosome 9.

Authors:  T A Donlon; R E Magenis
Journal:  Chromosoma       Date:  1981       Impact factor: 4.316

4.  Heterogeneity of human chromosome 9 constitutive heterochromatin as revealed by sequential distamycin A/DAPI staining and C-banding.

Authors:  C H Buys; W L Gouw; J A Blenkers; C H van Dalen
Journal:  Hum Genet       Date:  1981       Impact factor: 4.132

Review 5.  Counterstain-enhanced chromosome banding.

Authors:  D Schweizer
Journal:  Hum Genet       Date:  1981       Impact factor: 4.132

6.  Heteromorphic variants of chromosome 9.

Authors:  Nadezda Kosyakova; Ani Grigorian; Thomas Liehr; Marina Manvelyan; Isabella Simonyan; Hasmik Mkrtchyan; Rouben Aroutiounian; Anna D Polityko; Anna I Kulpanovich; Tatiana Egorova; Evgenia Jaroshevich; Alla Frolova; Natalia Shorokh; Irina V Naumchik; Marianne Volleth; Isolde Schreyer; Heike Nelle; Markus Stumm; Rolf-Dieter Wegner; Gisela Reising-Ackermann; Martina Merkas; Lukretija Brecevic; Thomas Martin; Laura Rodríguez; Samarth Bhatt; Monika Ziegler; Katharina Kreskowski; Anja Weise; Ali Sazci; Svetlana Vorsanova; Marcelo de Bello Cioffi; Emel Ergul
Journal:  Mol Cytogenet       Date:  2013-04-01       Impact factor: 2.009

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.